TFF Pharmaceuticals Inc (TFFP)
2.00
-0.16
(-7.41%)
USD |
NASDAQ |
Sep 27, 16:00
1.99
-0.01
(-0.50%)
After-Hours: 20:00
TFF Pharmaceuticals Cash from Operations (Quarterly): -3.254M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.254M |
| March 31, 2024 | -3.144M |
| December 31, 2023 | -4.214M |
| September 30, 2023 | -3.001M |
| June 30, 2023 | -4.458M |
| March 31, 2023 | -4.366M |
| December 31, 2022 | -7.702M |
| September 30, 2022 | -7.380M |
| June 30, 2022 | -5.014M |
| March 31, 2022 | -7.246M |
| December 31, 2021 | -10.88M |
| Date | Value |
|---|---|
| September 30, 2021 | -7.192M |
| June 30, 2021 | -5.890M |
| March 31, 2021 | -5.591M |
| December 31, 2020 | -6.233M |
| September 30, 2020 | -4.256M |
| June 30, 2020 | -3.775M |
| March 31, 2020 | -2.352M |
| December 31, 2019 | -4.307M |
| September 30, 2019 | -3.071M |
| June 30, 2019 | -1.722M |
| March 31, 2019 | -2.116M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.88M
Minimum
Dec 2021
-2.352M
Maximum
Mar 2020
-5.166M
Average
-4.412M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.425M |
| Free Cash Flow | -13.61M |
| Free Cash Flow Per Share (Quarterly) | -0.8872 |
| Free Cash Flow to Equity (Quarterly) | -3.254M |
| Free Cash Flow Yield | -263.7% |